53 related articles for article (PubMed ID: 1588926)
1. Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine.
Wright LL; Painter GR
Mol Pharmacol; 1992 May; 41(5):957-62. PubMed ID: 1588926
[TBL] [Abstract][Full Text] [Related]
2. Membrane permeation characteristics of 5'-modified thymidine analogs.
Domin BA; Mahony WB; Koszalka GW; Porter DJ; Hajian G; Zimmerman TP
Mol Pharmacol; 1992 May; 41(5):950-6. PubMed ID: 1588925
[TBL] [Abstract][Full Text] [Related]
3. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
August EM; Birks EM; Prusoff WH
Mol Pharmacol; 1991 Feb; 39(2):246-9. PubMed ID: 1847498
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel thymidine analogs as antitumor and antiviral agents.
Chen X; Bastow K; Goz B; Kucera LS; Morris-Natschke SL; Ishaq KS
J Med Chem; 1996 Aug; 39(17):3412-7. PubMed ID: 8765526
[TBL] [Abstract][Full Text] [Related]
5. 3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.
Zimmerman TP; Mahony WB; Prus KL
J Biol Chem; 1987 Apr; 262(12):5748-54. PubMed ID: 3471758
[TBL] [Abstract][Full Text] [Related]
6. 2',3'-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusion.
Domin BA; Mahony WB; Zimmerman TP
Biochem Biophys Res Commun; 1988 Aug; 154(3):825-31. PubMed ID: 2841933
[TBL] [Abstract][Full Text] [Related]
7. Kinetic parameters and recognition of thymidine analogues with varying functional groups by thymidine phosphorylase.
Hatano A; Harano A; Takigawa Y; Naramoto Y; Toda K; Nakagomi Y; Yamada H
Bioorg Med Chem; 2008 Apr; 16(7):3866-70. PubMed ID: 18272369
[TBL] [Abstract][Full Text] [Related]
8. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
Chen LL; Yao J; Yang JB; Yang J
Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy.
Al-Madhoun AS; Johnsamuel J; Barth RF; Tjarks W; Eriksson S
Cancer Res; 2004 Sep; 64(17):6280-6. PubMed ID: 15342416
[TBL] [Abstract][Full Text] [Related]
10. Computational investigation of hydrogen abstraction from 2-aminoethanol by the 1,5-dideoxyribose-5-yl radical: a model study of a reaction occurring in the active site of ethanolamine ammonia lyase.
Semialjac M; Schwarz H
Chemistry; 2004 Jun; 10(11):2781-8. PubMed ID: 15195308
[TBL] [Abstract][Full Text] [Related]
11. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
Fasano WJ; McDougal JN
Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.
Thomas BF; Compton DR; Martin BR
J Pharmacol Exp Ther; 1990 Nov; 255(2):624-30. PubMed ID: 2173751
[TBL] [Abstract][Full Text] [Related]
13. Comparative diffusion of drugs through bronchial tissue.
van Zyl JM; Derendinger B; Seifart HI; Van der Bijl P
Int J Pharm; 2008 Jun; 357(1-2):32-6. PubMed ID: 18295419
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
15. Water permeability, Lp, of the mouse sperm plasma membrane and its activation energy are strongly dependent on interaction of the plasma membrane with the sperm cytoskeleton.
Noiles EE; Thompson KA; Storey BT
Cryobiology; 1997 Aug; 35(1):79-92. PubMed ID: 9302770
[TBL] [Abstract][Full Text] [Related]
16. How fatty acids of different chain length enter and leave cells by free diffusion.
Kamp F; Hamilton JA
Prostaglandins Leukot Essent Fatty Acids; 2006 Sep; 75(3):149-59. PubMed ID: 16829065
[TBL] [Abstract][Full Text] [Related]
17. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model.
Tian XJ; Yang XW; Yang X; Wang K
Int J Pharm; 2009 Feb; 367(1-2):58-64. PubMed ID: 18848870
[TBL] [Abstract][Full Text] [Related]
18. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
Sanghani PC; Jackman A; Evans VR; Thornton T; Hughes L; Calvert AH; Moran RG
Mol Pharmacol; 1994 Feb; 45(2):341-51. PubMed ID: 8114682
[TBL] [Abstract][Full Text] [Related]
19. Extravascular transport of drugs in tumor tissue: effect of lipophilicity on diffusion of tirapazamine analogues in multicellular layer cultures.
Pruijn FB; Sturman JR; Liyanage HD; Hicks KO; Hay MP; Wilson WR
J Med Chem; 2005 Feb; 48(4):1079-87. PubMed ID: 15715475
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell permeability of a series of peptidic HIV protease inhibitors: aminoterminal substituent effects.
Conradi RA; Hilgers AR; Burton PS; Hester JB
J Drug Target; 1994; 2(2):167-71. PubMed ID: 8069595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
